Excitingly, a Chimeric antigen receptor (CAR) T‐cell therapy using the extracellular domain of Dectin‐1 to provide the CAR‐T cells with a specificity for β‐glucans has shown promising results in treating invasive fungal infections.80 Here, CLEC7A is linked to fungal infectious disease.